Mineralocorticoid receptor antagonist added to angiotensin-converting enzyme inhibitor ameliorates the transition to diastolic heart failure by decreasing myocardial oxidative stress

被引：0
|
作者：
Kimata, H
Obata, K
Saka, M
Cheng, XW
Hayashi, K
Ichihara, S
机构：
[1] Nagoya Univ, Nagoya, Aichi, Japan
[2] Mie Univ, Tsu, Mie 514, Japan
来源：
CIRCULATION | 2005年 / 112卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2183
引用
收藏
页码：U512 / U512
页数：1
相关论文
共 50 条
  • [1] Prognostic impact of angiotensin-converting enzyme inhibitor therapy in diastolic heart failure
    Tribouilloy, Christophe
    Rusinaru, Dan
    Leborgne, Laurent
    Peltier, Marcel
    Massy, Ziad
    Slama, Michel
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (05): : 639 - 644
  • [2] Beneficial effect of replacing of angiotensin-converting enzyme inhibitor with angiotensin II antagonist for heart failure patients
    Hara, Y
    Hamada, M
    Shigematsu, Y
    Ohtsuka, T
    Hiwada, K
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2002, 27 (04) : 267 - 271
  • [3] Angiotensin-converting enzyme inhibitor use in diastolic heart failure is associated with a reduced risk of death
    Philbin, EF
    Rocco, TA
    Lindenmuth, NW
    Jenkins, PL
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 232A - 232A
  • [4] Angiotensin-converting enzyme inhibitor and/or angiotensin receptor antagonist for the postmyocardial infarction patient
    Scott, Robert L.
    CARDIOLOGY CLINICS, 2008, 26 (01) : 73 - +
  • [5] Combined therapy with an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor in heart failure
    Struckman, DR
    Rivey, MP
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (02) : 242 - 248
  • [6] Diastolic heart failure NYHA stage IV: angiotensin converting enzyme inhibitor or angiotensin II antagonist ... or association?
    Ory, J. P.
    Debieuvre, D.
    Bourscheid, D.
    Lebrun, C.
    Vitrey, F.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 122 - 122
  • [7] Evaluation of angiotensin-converting enzyme inhibitor in congestive heart failure
    Matsuo, H
    INTERNAL MEDICINE, 1996, 35 (01) : 65 - 67
  • [8] Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients
    Keidar, S
    Gamliel-Lazarovich, A
    Kaplan, M
    Pavlotzky, E
    Hamoud, S
    Hayek, T
    Karry, R
    Abassi, Z
    CIRCULATION RESEARCH, 2005, 97 (09) : 946 - 953
  • [9] Combination therapy with an angiotensin-converting-enzyme inhibitor and an angiotensin II receptor antagonist ameliorates microinflammation and oxidative stress in patients with diabetic nephropathy
    Nakamura, Akihiko
    Shikata, Kenichi
    Nakatou, Tatsuaki
    Kitamura, Takuya
    Kajitani, Nobuo
    Ogawa, Daisuke
    Makino, Hirofumi
    JOURNAL OF DIABETES INVESTIGATION, 2013, 4 (02): : 195 - 201
  • [10] Comparative efficacy of angiotensin-converting enzyme inhibitor and its combination with beta-blocker or angiotensin receptor blocker in isolated diastolic heart failure
    Adamyan, KG
    Nargizyan, AB
    Tumasyan, LR
    EUROPEAN HEART JOURNAL, 2004, 25 : 583 - 583
12345